CORE--PEPTIDE BIOCHEMISTRY
核心--肽生物化学
基本信息
- 批准号:6651774
- 负责人:
- 金额:$ 13.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Peptide Biochemistry Core (Core B) has two main goals: 1) to generate
and maintain primary phage display libraries as tools for the proposed
studies, 2) to design and execute experiments to isolate and characterize
function-blocking peptides against the target proteins under
investigation. Distinct strategies will be applied to each specific
application. For proteins that have already been cloned, recombinant
proteins will be purified and immobilized on solid supports. These include
ephrin-A1 (formerly B61) fused to human IgG (ephrin-A1/IgG) (Project 1),
Fas ligand that is immuno-affinity purified from a producing cell line
(Project 2), and EGF residue K652-A674 fused to GST (Project 5). Primary
peptide phage display libraries will be selected on the recombinant
proteins. Selected phage will be amplified and selected on the target
protein again. Following such repeated, peptide coding sequences from
phage capable of specifically binding to target proteins will be fused to
GST or synthesize. They will be used to test for blocking Eph kinase
signaling (Project 1), or Fas-Fas ligand mediated apoptosis (Project 2).
In project 5, the peptide sequences themselves will be used to deduce
proteins that interact with EGFR K652-A674. Since functional recombinant
proteins are not available for ion channel ROMK1 (Project 3), we will
express it on Sf9 and CHO-Lec-1. By altering phage selection on insect and
mammalian cells overexpressing the channel the non-specific binding
associated with total cell panning will be minimized. Peptides will be
synthesized and characterized using the channel clamping systems.
肽生物化学核心(Core B)有两个主要目标:1)生成
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bingcheng Wang其他文献
Bingcheng Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bingcheng Wang', 18)}}的其他基金
Eph Kinase Signaling In Renal Epithelial Cells
肾上皮细胞中的 Eph 激酶信号传导
- 批准号:
7903725 - 财政年份:2009
- 资助金额:
$ 13.53万 - 项目类别:
Eph Kinase Signaling In Renal Epithelial Cells
肾上皮细胞中的 Eph 激酶信号传导
- 批准号:
8091272 - 财政年份:2008
- 资助金额:
$ 13.53万 - 项目类别:
Eph Kinase Signaling In Renal Epithelial Cells
肾上皮细胞中的 Eph 激酶信号传导
- 批准号:
7588914 - 财政年份:2008
- 资助金额:
$ 13.53万 - 项目类别:
EphA2 Agonists as Novel Inhibitors of Tumor Progression
EphA2 激动剂作为肿瘤进展的新型抑制剂
- 批准号:
6711809 - 财政年份:2002
- 资助金额:
$ 13.53万 - 项目类别:














{{item.name}}会员




